BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song D, Liang H, Qu B, Li Y, Liu J, Chen C, Zhang D, Zhang X, Gao A. Moxidectin inhibits glioma cell viability by inducing G0/G1 cell cycle arrest and apoptosis. Oncol Rep 2018;40:1348-58. [PMID: 30015956 DOI: 10.3892/or.2018.6561] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Li J, Xia L. Plant-derived natural products and combination therapy in liver cancer. Front Oncol 2023;13:1116532. [PMID: 36865794 DOI: 10.3389/fonc.2023.1116532] [Reference Citation Analysis]
2 Wang J, Liu Y, Zhang A, Yu W, Lei Q, Xiao B, Luo Z. Investigational Microbiological Therapy for Glioma. Cancers (Basel) 2022;14. [PMID: 36497459 DOI: 10.3390/cancers14235977] [Reference Citation Analysis]
3 Mao Y, Xie H, Shu D, Cheng L, Lan J, Pan K. Moxidectin induces autophagy arrest in colorectal cancer. Med Oncol 2022;39:211. [PMID: 36175702 DOI: 10.1007/s12032-022-01799-5] [Reference Citation Analysis]
4 Gu S, Peng Z, Wu Y, Wang Y, Lei D, Jiang X, Zhao H, Fu P. COL5A1 Serves as a Biomarker of Tumor Progression and Poor Prognosis and May Be a Potential Therapeutic Target in Gliomas. Front Oncol 2021;11:752694. [PMID: 34868960 DOI: 10.3389/fonc.2021.752694] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu Z, Zhang W, Cheng X, Wang H, Bian L, Wang J, Han Z, Wang Y, Lian X, Liu B, Ren Z, Zhang B, Jiang Z, Lin Z, Gao Y. Overexpressed XRCC2 as an independent risk factor for poor prognosis in glioma patients. Mol Med 2021;27:52. [PMID: 34051735 DOI: 10.1186/s10020-021-00316-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Gu Y, Zhang L, Yang H, Zhuang J, Sun Z, Guo J, Guan M. Nanosecond pulsed electric fields impair viability and mucin expression in mucinous colorectal carcinoma cell. Bioelectrochemistry 2021;141:107844. [PMID: 34052542 DOI: 10.1016/j.bioelechem.2021.107844] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Li YQ, Zheng Z, Liu QX, Lu X, Zhou D, Zhang J, Zheng H, Dai JG. Repositioning of Antiparasitic Drugs for Tumor Treatment. Front Oncol 2021;11:670804. [PMID: 33996598 DOI: 10.3389/fonc.2021.670804] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
8 Liu Y, Wu H, Jing J, Li H, Dong S, Meng Q. Downregulation of hsa_circ_0001836 Induces Pyroptosis Cell Death in Glioma Cells via Epigenetically Upregulating NLRP1. Front Oncol 2021;11:622727. [PMID: 33869006 DOI: 10.3389/fonc.2021.622727] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
9 Liu J, Liang H, Khilji S, Li H, Song D, Chen C, Wang X, Zhang Y, Zhao N, Li X, Gao A. Moxidectin induces Cytostatic Autophagic Cell Death of Glioma Cells through inhibiting the AKT/mTOR Signalling Pathway. J Cancer 2020;11:5802-11. [PMID: 32913473 DOI: 10.7150/jca.46697] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Mezzatesta C, Abduli L, Guinot A, Eckert C, Schewe D, Zaliova M, Vinti L, Marovca B, Tsai YC, Jenni S, Aguade-Gorgorio J, von Stackelberg A, Schrappe M, Locatelli F, Stanulla M, Cario G, Bourquin JP, Bornhauser BC. Repurposing anthelmintic agents to eradicate resistant leukemia. Blood Cancer J 2020;10:72. [PMID: 32591499 DOI: 10.1038/s41408-020-0339-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]